<scp>DNA</scp> methylation and expression of <scp> <i>MAPRE3</i> </scp> affect overall survival of early‐stage non‐small cell lung cancer patients
). We conclude MAPRE3 may predict NSCLC prognosis and influence the prognostic benefit of smoking cessation.
Authors
- Manel Esteller (ORCID: https://orcid.org/0000-0003-4490-6093)
- Fengqian Chen (ORCID: https://orcid.org/0000-0002-2330-6403)
- Maria Moksnes Bjaanæs (ORCID: https://orcid.org/0000-0001-7126-9064)
- Ruyang Zhang (ORCID: https://orcid.org/0000-0003-3861-4297)
- Ruili Hou
- Maria Planck (ORCID: https://orcid.org/0000-0001-7893-6755)
- Åslaug Helland (ORCID: https://orcid.org/0000-0002-5520-0275)
- Johan Staaf (ORCID: https://orcid.org/0000-0001-5254-5115)
- S Li
- J H Cheng
- David C. Christiani
- Chao Chen
- Anna Karlsson
- Xiaofei Cao (ORCID: https://orcid.org/0000-0002-6676-4658)
- Xiaoyuan Zheng
Institutions
- Institució Catalana de Recerca i Estudis Avançats (ES)
- Harvard University (US)
- University of Oslo (NO)
- Lund University (SE)
- China International Science and Technology Cooperation (CN)
- Massachusetts General Hospital (US)
- Josep Carreras Leukaemia Research Institute (ES)
- Cancer Registry of Norway (NO)
- Second Affiliated Hospital of Nanjing Medical University (CN)
- Cancer Genetics (United States) (US)
- Changzhou No.2 People's Hospital (CN)
- Changzhou University (CN)
- Centro de Investigación Biomédica en Red de Cáncer (ES)
- Universitat de Barcelona (ES)
- Nanjing Medical University (CN)
Publication Details
- Journal
- Molecular Oncology
- Published
- 2026-04-25
- DOI
- https://doi.org/10.1002/1878-0261.70260
- Primary Topic
- Epigenetics and DNA Methylation
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- Priority Academic Program Development of Jiangsu Higher Education Institutions
- National Institutes of Health